NewsResearch
Ipilimumab shows a survival benefit in melanoma
A dated cancer milestone (2010): the first checkpoint inhibitor to extend survival in a cancer. Why it mattered, its limits, and how the field evolved.
Original commentary from the Cancer Explained editorial team.
Historical context: this page explains an event dated 2010. It was published as an explainer on July 12, 2026 and is not breaking news.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
Historical milestone — this page describes an event dated 2010. It is not current breaking news.
In brief
Ipilimumab shows a survival benefit in melanoma (2010). The first checkpoint inhibitor to extend survival in a cancer.
What happened
Ipilimumab shows a survival benefit in melanoma, dated to 2010. The first checkpoint inhibitor to extend survival in a cancer. Specific dates and attributions are held for verification against historical sources.
Why it changed cancer care or understanding
The first checkpoint inhibitor to extend survival in a cancer. Milestones like this help explain how today's cancer care and understanding came to be.
The context of the time
Set against the knowledge and tools of its time, this step marked a meaningful change in direction.
What this story cannot tell you
- A historical milestone reflects the knowledge and standards of its era, not today's.
- Early breakthroughs were often limited, and the field kept evolving afterward.
How the field evolved afterward
Later research built on, refined, and in some cases corrected this development.
Present-day relevance
Melanoma is a cancer that begins in melanocytes, the cells that give skin its color. It is less common than other skin cancers but more likely to spread. Guidance emphasizes watching your own skin for change and seeing a clinician about suspicious spots; routine whole-body screening is an individual decision.
Sources
This article was written from the sources below, which were checked on the source-check date shown above.
How this article was prepared
Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.
Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.